Global Virtual Diagnostics market projected to drive by the technological advancements in diagnostics and the rising geriatric population across the globe. Global Virtual Diagnostics market likely to grow with a remarkable rate during the forecast period, 2020-2027. It is owing to growing applications of artificial intelligence and machine learning technologies in the healthcare industry, coupled with the rising adoption rate of smartphones within various regions. Moreover, the need for artificial intelligence-based diagnostics is contributing to market growth.
The system which can be connected to any place through the Internet and medical artificial intelligence can provide accessible and affordable medical services for everyone, which will fuel the global virtual diagnostics industry in the upcoming periods. Virtual Diagnostics is taken care of by physicians to examine ECG data captured by the IoT based sensors, and store patient records for easy retrieval and send the information for secure storage in the cloud. AI-based diagnosis analyses diseases with a high degree of accuracy.
Furthermore, the government’s regulatory policies for the healthcare system, technological advancements in the field, and increasing investment by major players for easy and affordable detection do diseases will accelerate the demand for the virtual diagnostics industry in the future. The deep cultivation of artificial intelligence in the medical and health field is expected to alleviate bottlenecks in medical diagnosis and treatment fields such as scarce resources of high-quality doctors, heavily repeated workloads, and uneven quality of diagnosis. In addition, the augmentation in demand for AI for unaddressed clinical needs and the rising demand for improved diagnostic technologies will influence the global virtual diagnostics market size in the anticipated periods.
Type of Diagnosis Overview in the Global Virtual Diagnostics market
Based on the type of diagnosis, the global Virtual Diagnostics market classified into Gastrointestinal Virtual Diagnostics, Ophthalmology Virtual Diagnostics, Cardiology Virtual Diagnostics, Pathology Virtual Diagnostics, and Others. The Pathology Virtual Diagnostics segment likely to lead the market by 2027, as it excludes negative samples and indicates positive areas, assists pathologists in improving the efficiency of pathological diagnosis, or replaces pathologists in the diagnosis of certain diseases. The imaging applications include AI-assisted rapid imaging and image diagnosis.
AI-assisted imaging can effectively shorten the examination time and reduce radiation damage to the human body. On the other hand, machine learning training algorithms can be used to implement the computer-based image diagnosis of diseases.
End-User Overview in the Global Virtual Diagnostics market
Based on end-user, the global Virtual Diagnostics market categorized into Hospitals, Clinics, Ambulatory Surgical Centers, and Others. Hospitals segments dominate the market by 2027 as they generate huge demand for virtual diagnosis coupled with the rise in the number of patients and the increase in hospitalization across the globe.
Regional Overview in the Global Virtual Diagnostics market
By geography, the Global Virtual Diagnostics market segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America accounted for a major share in 2019. It will continue supremacy by 2027, owing to the presence of a well-equipped diagnostic infrastructure, huge technological advancements in healthcare systems, coupled with high investment by key players in AI-based diagnostics systems in these regions.
Global Virtual Diagnostics market: Competitive Landscape
Companies such as AliveCor Inc., Cardiologs Technologies, CapsoVision, Inc, Eyenuk, Inc, Healthy.io Ltd., hearX IP (Pty) Ltd, Hill-Rom Holdings, Inc., IDx Technologies Inc., Medtronic Plc., Monitored Therapeutics Inc., Olympus Corporation, Phelcom Technologies, and ResApp Health Limited are the key players in the Global Virtual Diagnostics Market.
1. Research Strategic Development
1.1. Market Modelling
1.2. Product Analysis
1.3. Market Trend and Economic Factors Analysis
1.4. Market Segmental Analysis
1.5. Geographical Mapping
1.6. Country Wise Segregation
2. Research Methodology
2.1. Identification of Target Market
2.2. Data Acquisition
2.3. Refining of Data/ Data Transformations
2.4. Data Validation through Primary Techniques
2.5. Exploratory Data Analysis
2.6. Graphical Techniques/Analysis
2.7. Quantitative Techniques/Analysis
2.8. Visual Result/Presentation
3. Executive Summary
4. Market Insights
4.1. Economic Factor Analysis
4.1.1. Drivers
4.1.2. Trends
4.1.3. Opportunities
4.1.4. Challenges
4.2. Technological Landscape
4.3. Competitors & Product Analysis
4.4. Regulatory Framework
4.5. Company market share analysis, 2019
4.6. Porter’s Five forces analysis
4.7. New Investment Analysis
4.8. PESTEL Analysis
5. Global Virtual Diagnostics Market Overview
5.1. Market Size & Forecast, 2016-2027
5.1.1. Demand
5.1.1.1. By Value (USD Million)
5.2. Market Share & Forecast, 2016-2027
5.2.1. By Type of Diagnosis
5.2.1.1. Gastrointestinal Virtual Diagnostics
5.2.1.2. Ophthalmology Virtual Diagnostics
5.2.1.3. Cardiology Virtual Diagnostics
5.2.1.4. Pathology Virtual Diagnostics
5.2.1.5. Others
5.2.2. By End-User
5.2.2.1. Hospitals
5.2.2.2. Clinics
5.2.2.3. Ambulatory Surgical Centers
5.2.2.4. Others
5.2.3. By Region
5.2.3.1. North America
5.2.3.2. Europe
5.2.3.3. Asia Pacific
5.2.3.4. South America
5.2.3.5. Middle East & Africa
6. North America Virtual Diagnostics Market Overview
6.1. North America Virtual Diagnostics Market Size & Forecast, 2016-2027
6.1.1. Demand
6.1.1.1. By Value (USD Million)
6.2. North America Virtual Diagnostics Market Share & Forecast, 2016-2027
6.2.1. By Type of Diagnosis
6.2.1.1. Gastrointestinal Virtual Diagnostics
6.2.1.2. Ophthalmology Virtual Diagnostics
6.2.1.3. Cardiology Virtual Diagnostics
6.2.1.4. Pathology Virtual Diagnostics
6.2.1.5. Others
6.2.2. By End-User
6.2.2.1. Hospitals
6.2.2.2. Clinics
6.2.2.3. Ambulatory Surgical Centers
6.2.2.4. Others
6.2.3. By Country
6.2.3.1. US
6.2.3.2. Canada
6.2.3.3. Mexico
6.2.4. Company Market Share (Top 3-5)
6.2.5. Economic Impact Study on North America Virtual Diagnostics Market
7. Europe Virtual Diagnostics Market Overview
7.1. Europe Virtual Diagnostics Market Size & Forecast, 2016-2027
7.1.1. Demand
7.1.1.1. By Value (USD Million)
7.2. Europe Virtual Diagnostics Market Share & Forecast, 2016-2027
7.2.1. By Type of Diagnosis
7.2.1.1. Gastrointestinal Virtual Diagnostics
7.2.1.2. Ophthalmology Virtual Diagnostics
7.2.1.3. Cardiology Virtual Diagnostics
7.2.1.4. Pathology Virtual Diagnostics
7.2.1.5. Others
7.2.2. By End-User
7.2.2.1. Hospitals
7.2.2.2. Clinics
7.2.2.3. Ambulatory Surgical Centers
7.2.2.4. Others
7.2.3. By Country
7.2.3.1. Germany
7.2.3.2. UK
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Rest of Europe
7.2.4. Company Market Share (Top 3-5)
7.2.5. Economic Impact Study on Europe Virtual Diagnostics Market
8. Asia Pacific Virtual Diagnostics Market Overview
8.1. Asia Pacific Virtual Diagnostics Market Size & Forecast, 2016-2027
8.1.1. Demand
8.1.1.1. By Value (USD Million)
8.2. Asia Pacific Virtual Diagnostics Market Share & Forecast, 2016-2027
8.2.1. By Type of Diagnosis
8.2.1.1. Gastrointestinal Virtual Diagnostics
8.2.1.2. Ophthalmology Virtual Diagnostics
8.2.1.3. Cardiology Virtual Diagnostics
8.2.1.4. Pathology Virtual Diagnostics
8.2.1.5. Others
8.2.2. By End-User
8.2.2.1. Hospitals
8.2.2.2. Clinics
8.2.2.3. Ambulatory Surgical Centers
8.2.2.4. Others
8.2.3. By Country
8.2.3.1. China
8.2.3.2. India
8.2.3.3. Japan
8.2.3.4. Australia
8.2.3.5. Rest of Asia Pacific
8.2.4. Company Market Share (Top 3-5)
8.2.5. Economic Impact Study on Asia Pacific Virtual Diagnostics Market
9. South America Virtual Diagnostics Market Overview
9.1. South America Virtual Diagnostics Market Size & Forecast, 2016-2027
9.1.1. Demand
9.1.1.1. By Value (USD Million)
9.2. South America Virtual Diagnostics Market Share & Forecast, 2016-2027
9.2.1. By Type of Diagnosis
9.2.1.1. Gastrointestinal Virtual Diagnostics
9.2.1.2. Ophthalmology Virtual Diagnostics
9.2.1.3. Cardiology Virtual Diagnostics
9.2.1.4. Pathology Virtual Diagnostics
9.2.1.5. Others
9.2.2. By End-User
9.2.2.1. Hospitals
9.2.2.2. Clinics
9.2.2.3. Ambulatory Surgical Centers
9.2.2.4. Others
9.2.3. By Country
9.2.3.1. Brazil
9.2.3.2. Argentina
9.2.3.3. Rest of South America
9.2.4. Company Market Share (Top 3-5)
9.2.5. Economic Impact Study on South America Virtual Diagnostics Market
10. Middle East & Africa Virtual Diagnostics Market Overview
10.1. Middle East & Africa Virtual Diagnostics Market Size & Forecast, 2016-2027
10.1.1. Demand
10.1.1.1. By Value (USD Million)
10.2. Middle East & Africa Virtual Diagnostics Market Share & Forecast, 2016-2027
10.2.1. By Type of Diagnosis
10.2.1.1. Gastrointestinal Virtual Diagnostics
10.2.1.2. Ophthalmology Virtual Diagnostics
10.2.1.3. Cardiology Virtual Diagnostics
10.2.1.4. Pathology Virtual Diagnostics
10.2.1.5. Others
10.2.2. By End-User
10.2.2.1. Hospitals
10.2.2.2. Clinics
10.2.2.3. Ambulatory Surgical Centers
10.2.2.4. Others
10.2.3. By Country
10.2.3.1. Saudi Arabia
10.2.3.2. UAE
10.2.3.3. South Africa
10.2.3.4. Rest of Middle East & Africa
10.2.4. Company Market Share (Top 3-5)
10.2.5. Economic Impact Study on Middle East & Africa Virtual Diagnostics Market
11. Competitor Analysis
11.1. Company Description
11.2. Financial Analysis
11.3. Key Products
11.4. Key Management Personnel
11.5. Contact Address
11.6. SWOT Analysis
11.7. Company Profile
11.7.1. AliveCor Inc.
11.7.2. Cardiologs Technologies
11.7.3. CapsoVision, Inc
11.7.4. Eyenuk, Inc
11.7.5. Healthy.io Ltd.
11.7.6. hearX IP (Pty) Ltd
11.7.7. Hill-Rom Holdings, Inc.
11.7.8. IDx Technologies Inc.
11.7.9. Medtronic Plc.
11.7.10. Monitored Therapeutics Inc.
11.7.11. Olympus Corporation
11.7.12. Phelcom Technologies
11.7.13. ResApp Health Limited
11.7.14. Other Prominent Players